BiotechTube
Home/Draig Therapeutics/Ivana Magovčević-Liebisch
IM

Ivana Magovčević-Liebisch

President and Chief Executive Officer

Draig Therapeutics

Therapeutic Areas

NeuropsychiatryMajor Depressive Disorder

Draig Therapeutics Pipeline

DrugIndicationPhase
DT-101Major Depressive Disorder (MDD)Phase 2
GABA-A Receptor ModulatorsUndisclosed Neuropsychiatric DisordersPreclinical

Leadership Team at Draig Therapeutics

DE
Douglas E. Williams, Ph.D.
Chair of the Board of Directors
View full Draig Therapeutics profile